多家跨国企业齐聚 上海外高桥保税区渐成医美企业地区总部集聚地

Core Insights - The medical aesthetics industry has become a significant component of the Shanghai Waigaoqiao Free Trade Zone, attracting multinational companies' regional headquarters [1][2] - Shanghai's biopharmaceutical industry is one of the three leading industries in the city's goal to create a world-class industrial cluster [1] - The Waigaoqiao Free Trade Zone has developed into the largest economic scale and most functionally diverse customs special supervision area in China [1] Industry Overview - The global medical aesthetics market is currently valued at approximately $23 billion, with an expected annual growth rate of around 7% over the next five years [2] - The Chinese medical aesthetics market is projected to reach ¥270 billion in 2024, reflecting a year-on-year growth of about 10% [2] Company Developments - Over 800 biopharmaceutical companies have gathered in the Waigaoqiao Free Trade Zone, supporting Shanghai's ambition to build a world-class biopharmaceutical industry cluster [1] - The Waigaoqiao Free Trade Zone offers significant policy and service advantages, making it an attractive location for multinational companies' China headquarters [2] - Allergan Aesthetics established its third wholly-owned subsidiary in China six years ago, marking a significant step in its development in the Chinese market [2]